Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of Pentoxifylline PKB171 Vaginal Gel in Healthy Volunteers
NCT07017114Phase 1Completed
- Sponsor
- Prokrea BCN
- Start
- Jan 2016
- Primary completion
- Apr 2016
- Modality
- Hydrogel Systems, Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of pentoxifylline PKB171 gel in male infertility and asthenozoospermia (4 arms), sponsored by Prokrea BCN. Primary endpoint: Maximum Tolerated Dose at 3 weeks. Started Jan 2016; status: completed.
02
Drugs
pentoxifylline PKB171 gel
03
Conditions
male infertilityasthenozoospermia
Beyond the preview
Go deeper on NCT07017114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07017114.